New Gene Identified That Causes Inherited Spinal Meningiomas
2/20/2013
Genetic medicine experts from Manchester Biomedical Research Centre at Saint Mary's Hospital and The University of Manchester have identified a new gene responsible for causing an inherited form of tumour, known as spinal meningioma. Professor Richard Marias, Director of the Paterson Institute Meningiomas are the commonest form of tumour affecting the brain and spine...
Study Of Blood Plasma Improves Our Understanding Of Thrombosis, Aneurysms And Arteriosclerosis
2/20/2013
The results are significant because they can help to improve our understanding of medical conditions, such as thrombosis, aneurysms and arteriosclerosis. The research team is publishing its results in Physical Review Letters and the American Physical Society has highlighted the work on its Physics website*, placing it on the Focus List of important physics news...
The Gene TP63 Linked To Worse Outcomes For Melanoma
2/20/2013
Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published in the Journal of Experimental Medicine. The scientists discovered that the gene TP63 is unexpectedly expressed in some melanoma and correlates significantly with a worse prognosis...
News From The Annals Of Internal Medicine: Feb. 19, 2013
2/20/2013
1. Acupuncture May be an Effective Alternative for Treating Seasonal Allergies Patients receiving acupuncture treatments for seasonal allergic rhinitis reported statistically significant improvements in symptoms and decreased use of medication compared to patients having standard treatment or sham acupuncture, but the clinical significance of the observed improvements is uncertain...
National Screening Benchmarks For Finding Polyps During A Colonoscopy Might Be Too Low
2/20/2013
Current national guidelines provide benchmarks regarding the number of polyps physicians should detect, on average, during a colonoscopy. Recent studies at Mayo Clinic's campus in Florida suggest these benchmarks may be too low...
Halting Metastasis Of Colon Cancer
2/20/2013
A Basque research consortium has managed to halt the progress of colon cancer and its metastasis in the liver in an experimental model with mice. This advance, that may open a new path for the future treatment of such pathologies, has been achieved by creating molecules which interfere with the adhesion of tumour cells to other cells of the organism...
Study Of Blood Plasma Improves Our Understanding Of Thrombosis, Aneurysms And Arteriosclerosis
2/20/2013
The results are significant because they can help to improve our understanding of medical conditions, such as thrombosis, aneurysms and arteriosclerosis. The research team is publishing its results in Physical Review Letters and the American Physical Society has highlighted the work on its Physics website*, placing it on the Focus List of important physics news...
A Smoking Gun In Lung Cancer Epigenetics
2/20/2013
Recent studies have identified correlations between cigarette smoke-induced microRNA (miRNA) expression and different aspects of lung cancer; however, it is unclear how miRNA expression directly contributes to carcinogenesis. MiRNAs regulate the expression of target genes and can have a significant impact on when and how well different gene products are expressed...
Discovery Of Pathway Controlling Cell Growth Has Implications For Cancer Treatment
2/20/2013
A Melbourne-based research team has discovered a genetic defect that can halt cell growth and force cells into a death-evading survival state. The finding has revealed an important mechanism controlling the growth of rapidly-dividing cells that may ultimately lead to the development of new treatments for diseases including cancer...
Hepatitis C New Study On Drug Treatment In Vivo And In Vitro
2/20/2013
Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e...